XML 139 R125.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule I: Condensed Financial Information of Registrant - Condensed Statements of Cashflows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 19, 2019
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:          
Net loss     $ (106,606) $ (54,032) $ (103,319)
Adjustments to reconcile net loss to net cash used in operating activities          
Loss on re measurement of private warrant liability     15,389 (2,427)  
Loss on remeasurement of earnout liability     18,519    
Interest expense (non-cash)     2,387 7,488 2,369
Change in operating assets and liabilities, net of acquisitions and divestitures          
Accrued expenses and other current liabilities     (15,981) (15,946) 7,704
Net cash used in operating activities     (34,777) (48,669) (29,335)
Cash flows from investing activities:          
Net cash used in investing activities     (263,433) (10,671) (5,208)
Cash flows from financing activities:          
Proceeds from recapitalization and PIPE financing       305,133  
Distribution to stockholders       (30,000)  
Transaction costs - recapitalization     (262) (5,652)  
Proceeds from debt issuance, net of fees   $ 3,000 413,537 66,190 31,300
Capped call transactions     (52,913)    
Proceeds from exercises of warrants     126,741    
Proceeds from exercises of stock options and Legacy Porch warrants     4,288 911 114
Income tax withholdings paid upon vesting of restricted stock units     (28,877)    
Net cash provided by financing activities     415,549 259,614 34,486
Net change in cash, cash equivalents, and restricted cash     117,339 200,274 (57)
Cash, cash equivalents, and restricted cash, beginning of period     207,453 7,179 7,236
Cash, cash equivalents, and restricted cash end of period $ 207,453   324,792 $ 207,453 $ 7,179
Parent          
Cash flows from operating activities:          
Net loss 3,731   (106,606)    
Adjustments to reconcile net loss to net cash used in operating activities          
Equity in net loss of subsidiary (1,360)   67,046    
Loss on re measurement of private warrant liability (2,427)   15,389    
Loss on remeasurement of earnout liability     18,519    
Interest expense (non-cash)     643    
Change in operating assets and liabilities, net of acquisitions and divestitures          
Accrued expenses and other current liabilities     930    
Net cash used in operating activities (56)   (4,079)    
Cash flows from investing activities:          
Paid to subsidiary (269,425)   (458,697)    
Net cash used in investing activities (269,425)   (458,697)    
Cash flows from financing activities:          
Proceeds from recapitalization and PIPE financing 305,133        
Distribution to stockholders (30,000)        
Transaction costs - recapitalization (5,652)        
Proceeds from debt issuance, net of fees     413,537    
Capped call transactions     (52,913)    
Proceeds from exercises of warrants     126,741    
Proceeds from exercises of stock options and Legacy Porch warrants     4,288    
Income tax withholdings paid upon vesting of restricted stock units     (28,877)    
Net cash provided by financing activities $ 269,481   $ 462,776